Anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients, study suggests
- Scientists have found that a biologic drug can delay Alzheimer's symptoms in specific patients, marking a significant step in treatment options.
- The study revealed a 50% reduction in risk of symptoms for 22 patients who took gantenerumab for an average of eight years.
- Dr. Eric McDade stated that these results suggest a possibility of delaying Alzheimer's progression.
- Dr. Tara Spires-Jones noted that while results are promising, they do not conclusively prove delayed onset, and some might avoid treatment due to modest benefits.
250 Articles
250 Articles
Early-onset Alzheimer’s: new drug shows promise in slowing the disease
The drug also caused a notable decrease in amyloid plaque buildup, which is a hallmark of Alzheimer's disease. ART-ur/ ShutterstockAlzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. Treatment options remain limited. But new data from a recent clinical tr…
Hungarian Researchers Explore New Alzheimer’s Treatment with Human Brain Cells
The Hungarian Centre of Excellence for Molecular Medicine (HCEMM) is taking a groundbreaking approach in the fight against neurodegenerative diseases by experimenting with live human brain tissue. Unlike traditional research, which heavily relies on animal models, this study uses brain cell samples donated by patients undergoing surgery. The team has recently secured 120 million forints in funding to further their work, which could lead to the d…
Alzheimer's subcommittee calls for 'outside the box' outreach in Alabama • Alabama Reflector
A doctor looks over an image of a brain. An Alabama Alzheimer's Task Force subcommittee met Tuesday to discuss strategies for increasing public awareness about Alzheimer's and related dementias. (Andrew Brookes/Getty Images)An Alabama Alzheimer’s Task Force subcommittee met Tuesday to discuss strategies for increasing public awareness about Alzheimer’s and related dementias. The public awareness and stigma reduction subcommittee on Tuesday discu…
Early detection of Alzheimer’s may start with simple test — Harvard Gazette
Health Sniffing out signs of trouble Mass General Brigham Communications March 25, 2025 3 min read Researchers develop at-home test to ID those at risk of Alzheimer’s years before symptoms appear When it comes to early detection of cognitive impairment, a new study suggests that the nose knows. Researchers from Harvard-affiliated Mass General Brigham developed olfactory tests — in which participants snif…
Coverage Details
Bias Distribution
- 71% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage